Skip to main content
Explore URMC


Michael Andrew Cummings, M.D.,M.S.

Contact Information

Phone Numbers

Appointment: (585) 335-8675

Administrative: (585) 275-2171

Fax: (585) 335-8697

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Radiation Oncology


Michael Cummings received his master's degree in Natural Sciences from SUNY University at Buffalo in 2009 and his medical degree from SUNY Upstate Medical University in 2013.

Dr. Cummings is an Assistant Professor of Radiation Oncology at the University of Rochester School of Medicine and Dentistry.

Dr. Cummings specializes in head and neck cancers, prostate cancer, bladder cancer and CNS metastatic disease. He believes the best approach is finding how the uniqueness of each person and their case fits into the published evidence and their own expectations.

Dr. Cummings is married with two sons and enjoys running in his free time.

He is a member of the American Society of Therapeutic Radiation Oncology.



BA | University of Rochester

MS | University at Buffalo, The State University of New York
Natural Sciences

MD | SUNY Upstate Medical University

Post-doctoral Training & Residency

07/01/2014 - 06/28/2018
Residency in Radiation Oncology at University of Rochester Medical Center - GME Office

07/01/2013 - 06/30/2014
Internship in Internal Medicine at Suny Upstate Medical University


Alpha Omega Alpha


Journal Articles

Cummings MA, Ma SJ, Hermann G, Serra L, Syed Y, Malhotra HK, Chen Y, Milano MT, Gomez-Suescun JA, Singh DP, Singh AK. "Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-small-cell Lung Cancer: A Two-institution Propensity-matched Analysis." Clinical lung cancer.. 2018 Nov 0; 19(6):511-517. Epub 2018 Jul 30.

Cummings M, Youn P, Bergsma DP, Usuki KY, Walter K, Sharma M, Okunieff P, Schell MC, Milano MT. "Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity." Neurosurgery.. 2018 Sep 1; 83(3):437-444.

Ma SJ, Cummings M, Serra LM, Syed YA, Hermann GM, Chen Y, Milano MT, Singh AK, Gomez-Suescun JA, Singh DP. "Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis." Clinical lung cancer.. 2018 May 0; 19(3):e297-e302. Epub 2017 Nov 26.